Original language | English |
---|---|
Pages (from-to) | 9026-9026 |
Number of pages | 1 |
Journal | Journal of Clinical Oncology |
Volume | 31 |
Issue number | 15 |
DOIs | |
Publication status | Published - 20 May 2013 |
Event | Annual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States Duration: 31 May 2013 → 4 Jun 2013 |
A phase II study of the multitargeted kinase inhibitor lenvatinib in patients with advanced BRAF wild-type melanoma
Steven O'Day, Rene Gonzalez, Kevin Kim, Bartosz Chmielowski, Richard Kefford, Georgina Long, Carmen Loquai, Charles Lance Cowey, Axel Hauschild, John D. Hainsworth, Peter Hersey, Frances Boyle, T. R. Jeffry Evans, Omid Hamid, Nicole Meneses, Corina Andresen, Min Ren, James P. O'Brien, Keith Flaherty
Research output: Contribution to journal › Meeting abstract